Home
Site Map
Search:
About Us
Overview
Management
Collaborations & Contractors
Business Strategy
Investors
Products & Technology
Clinical Development Programs
Scientific Rationale
Intellectual property
Markets
Obesity
Antipsychotic drug induced weight gain
Newsroom
Press Releases
Media Coverage
Contact Us
About Us
Products & Technology
Markets
Newsroom
Contact Us
Press Releases
Media Coverage
Press Releases
11.04.2007
Obecure Completes Patient Enrollment for Phase II Obesity Trial
13.03.2007
Obecure Initiates Phase II Weight Gain Prevention Study for Patients Taking Zyprexa
24.01.2007
Obecure Recruits First Patient in Phase II Obesity Study
22.01.2007
Eli Lilly to support Obecure Phase II trials
21.01.2007
Rodman and Renshaw Investments Selected to Lead Obecure Private Placement in US
12.12.2006
NIH Will Conduct Clinical Trials on Flagship Product OBE101
21.07.2006
Obecure Receives Permission from Canada for Clinical Trial
20.07.2006
Obecure To Enter the Appetite Stimulant Market
18.06.2006
Dr. Yaffa Beck Appointed CEO of ObeCure
<<
<
|
1
|
2
| > >> Total Pages: 2
©2007 All Rights Reserved to Obecure Ltd.
Disclaimer
Created by
Virtual Point Ltd.